Petros Pharmaceuticals, Inc. engages in men's health therapeutics. It is involved in sales, marketing, regulatory and medical affairs, finance, trade relations, pharma co-vigilance, market access relations, manufacturing, and distribution. It operates through the Prescription Medications and Medical Devices segments. The Prescription Medications segment handles Stendra, an FDA approved PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction, and H100, a topical formulation candidate for the treatment of acute Peyronie's disease. The Medical Devices segment consists of vacuum erection devices. The company was founded on May 14, 2020 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
18
Frequently Asked Questions
What is Market Cap of Petros Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Petros Pharmaceuticals Inc market cap is $1.19M.
What is the 52-week high for Petros Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Petros Pharmaceuticals Inc 52 week high is $16.25 as of September 14, 2025.
What is the 52-week low for Petros Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Petros Pharmaceuticals Inc 52 week low is $0.0226 as of September 14, 2025.
What is Petros Pharmaceuticals Inc stock price today?
Petros Pharmaceuticals Inc stock price today is $0.028.
What was Petros Pharmaceuticals Inc stock price yesterday?
Petros Pharmaceuticals Inc stock price yesterday was $0.0278.
What is the PE ratio of Petros Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Petros Pharmaceuticals Inc’s P/E ratio is 0.00.
What is the Price-to-Book ratio of Petros Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Petros Pharmaceuticals Inc P/B ratio is 0.2662.
What is the 50-day moving average of Petros Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Petros Pharmaceuticals Inc 50-day moving average is $0.0294.
How many employess does Petros Pharmaceuticals Inc has?